782 related articles for article (PubMed ID: 28507073)
1. Antibodies against
Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
[No Abstract] [Full Text] [Related]
2. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
[TBL] [Abstract][Full Text] [Related]
3. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
[TBL] [Abstract][Full Text] [Related]
5. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.
Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ
BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501
[TBL] [Abstract][Full Text] [Related]
6. The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of
Dyke JS; Huertas-Diaz MC; Michel F; Holladay NE; Hogan RJ; He B; Lafontaine ER
Virulence; 2020 Dec; 11(1):1024-1040. PubMed ID: 32799724
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
[TBL] [Abstract][Full Text] [Related]
8. The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection.
Zimmerman SM; Michel F; Hogan RJ; Lafontaine ER
PLoS One; 2015; 10(5):e0126437. PubMed ID: 25993100
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.
Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A
Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620
[TBL] [Abstract][Full Text] [Related]
10. Burkholderia pseudomallei Δ
Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
[No Abstract] [Full Text] [Related]
11. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
Galyov EE; Brett PJ; DeShazer D
Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
[TBL] [Abstract][Full Text] [Related]
12. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
Titball RW; Burtnick MN; Bancroft GJ; Brett P
Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
[TBL] [Abstract][Full Text] [Related]
13. The autotransporter protein BatA is a protective antigen against lethal aerosol infection with
Lafontaine ER; Chen Z; Huertas-Diaz MC; Dyke JS; Jelesijevic TP; Michel F; Hogan RJ; He B
Vaccine X; 2019 Apr; 1():100002. PubMed ID: 33826684
[TBL] [Abstract][Full Text] [Related]
14. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
[TBL] [Abstract][Full Text] [Related]
15. Development of Burkholderia mallei and pseudomallei vaccines.
Silva EB; Dow SW
Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
[TBL] [Abstract][Full Text] [Related]
16. Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.
Aschenbroich SA; Lafontaine ER; Hogan RJ
Expert Rev Vaccines; 2016 Sep; 15(9):1163-81. PubMed ID: 27010618
[TBL] [Abstract][Full Text] [Related]
17. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.
Memišević V; Kumar K; Zavaljevski N; DeShazer D; Wallqvist A; Reifman J
BMC Bioinformatics; 2016 Sep; 17():387. PubMed ID: 27650316
[TBL] [Abstract][Full Text] [Related]
18. Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Zou N; Newsome T; Li B; Tsai S; Lo SC
Exp Biol Med (Maywood); 2007 Apr; 232(4):550-6. PubMed ID: 17392491
[TBL] [Abstract][Full Text] [Related]
19. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.
Treviño SR; Permenter AR; England MJ; Parthasarathy N; Gibbs PH; Waag DM; Chanh TC
Infect Immun; 2006 Mar; 74(3):1958-61. PubMed ID: 16495574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
